New drug aims to stop dangerous nighttime hypos in type 1 diabetes
Disease control
Recruiting now
This study tests whether the drug ZT-01 can reduce nighttime low blood sugar (hypoglycemia) in adults with type 1 diabetes. Participants will inject ZT-01 or a placebo before bed for two 4-week periods while wearing a continuous glucose monitor. The goal is to see if ZT-01 lowers…
Phase: PHASE2 • Sponsor: Zucara Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC